European Registry on<i>Helicobacter pylori</i>management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

Olga P. Nyssen, Bojan Tepeš, Ángeles Pérez‐Aísa, +38

Gut

Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg)

Luís Bujanda, Olga P. Nyssen, Dino Vaira, +18

Antibiotics

Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)

Olga P. Nyssen, Ángeles Pérez‐Aísa, Bojan Tepeš, +45

The American Journal of Gastroenterology

Room for Improvement in the Treatment of Helicobacter pylori Infection

Olga P. Nyssen, Dino Vaira, Bojan Tepeš, +19

Journal of Clinical Gastroenterology

Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance

Luís Bujanda, Olga P. Nyssen, June Ramos, +33

The American Journal of Gastroenterology

Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus

Miroslav Vujasinović, Jelka Zaletel, Bojan Tepeš, +5

Pancreatology

Metabolic SyndromeDiabetesLow PrevalenceDiabetes MellitusPancreas Transplantation +2

<i>Helicobacter pylori</i>first‐line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on<i>H pylori</i>management (Hp‐EuReg)

Olga P. Nyssen, Ángeles Pérez‐Aísa, Bojan Tepeš, +45

Helicobacter

Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)

Olga P. Nyssen, Dino Vaira, Ángeles Pérez Aísa, +126

Clinical Gastroenterology and Hepatology

GastroenterologyEuropean RegistryClinical GastroenterologyEmpirical Second-line TherapyMedicine +1

Role of compliance in <i>Helicobacter pylori</i> eradication treatment: Results of the European Registry on <i>H. pylori</i> management

José María Huguet, Luis Ferrer‐Barceló, Patrícia Suárez, +44

United European Gastroenterology Journal

Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> infection between 2013 and 2021: results from the European registry on <i>H. pylori</i> management (Hp-EuReg)

Llum Olmedo, Xavier Calvet, Emili Gené, +43

Gut